Give your startup a boost over the competition
This exciting opportunity offers innovative entrepreneurs a chance to virtually pitch their company to top-tier investors and pharma execs.
Benefits of presenting at the Startup Springboard
Startup Springboard presenters who also register for BIO-Europe Spring® will have the opportunity to include a pre-recorded company presentation available on-demand to all attendees.
- VISIBILITY: Generate interest among top-tier investors and pharma execs through a company pitch
- CONNECT: Have a conversation with potential investors and partners during virtual networking
- ACQUIRE: Attain funding, infrastructure, and mentorship
Startup Criteria & Pricing
Applications for pitching can be submitted for consideration by startup companies who meet the following criteria:
Created in the past two years
Has fewer than five employees
Aggregate financing of 5 million EUR or less
Developing new therapeutic products, technology platforms, or digital medicine technologies
Startup Springboard package fee:
- 195.00 EUR*
Startup Springboard package will include:
- Registration to the Startup Springboard event
- 2-minute virtual company pitch
- Discounted registration to BIO-Europe Spring Digital ®
- *discounted price of 495.00 EUR (normal price 1,495.00 EUR)
- Complimentary 1-year membership to Connector, EBD Group’s new digital networking platform, enabling you to easily build your personal brand and industry relationships, and providing access to live networking, a steady stream of digital connections and on-demand content.
After applying, you will be notified via email with instructions on how to register for the Startup Springboard package. Registration for the Startup Springboard is required for each person attending, including the presenter of your company.
*You must meet the Startup Criteria to qualify for this rate
Startup Application Contact
If you are a qualifying startup, please APPLY FIRST before registering. If accepted, you will receive a code to process your registration.
If you have any additional questions, please contact: